HAM-5-GFP localization in WT and Δ<i>mak-2</i> germlings. by Wilfried Jonkers (160931)

“…(D) Western blots of WT, WT (<i>ham-5-gfp</i>) and Δ<i>mak-2</i> (<i>ham-5-gfp</i>) germlings with immunoprecipitated HAM-5-GFP probed with anti-GFP antibodies (right panel shows longer run showing higher mobility of HAM-5-GFP in wild type germlings) specifically detecting HAM-5-GFP (210 kD; <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004783#pgen.1004783.s004" target="_blank">Figure S4D</a>). …”

Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects:

Genes showing 1.5 fold expression decrease in D381 relative to heterozygous <i>TOR1/tor1</i>. by Wanjun Qi (5571359)

Sirt5 KO ameliorates cardiac dysfunction caused by TAC. by Mengli Zhang (6331172)

V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells. by Delphine Quélard (43727)

Loss of <i>SLC4A11</i> expression and CHED-associated <i>SLC4A11</i> mutations in hCEnC lead to decreased cell viability during tBH-induced oxidative stress. by Doug D. Chung (3611387)

The role of ULK1-11A/ATG13-4A unphosphorylatable mutant in cell cycle progression. by Zhiyuan Li (205620)

Compromised ROS response and stop-codon recoding with decreased Gpx and TrxR1 protein levels and activity in <i>Alkbh8</i>^<i>-/-</i> MEFs. by Lauren Endres (765718)

Viral dissemination of HTLV-1_WT and HTLV-1_p12KO. by Ramona Moles (8153181)

Data_Sheet_5_Chronic Neurobehavioral Impairments and Decreased Hippocampal Expression of Genes Important for Brain Glucose Utilization in a Mouse Model of Mild TBI.xlsx by Linda M. Huynh (9395591)

Klf5 and eIF5a suppress Ang II–induced expression of NOX1 in VSMCs. by Dong Ma (584680)

Subjects:

Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

“…<p>(A) DAOY cells were treated with CHX (100 μg/ml) for either 6 or 14 hours; for metabolic RNA labelling, 5-EU was added 2 hours before the sample collection. …”

Step-wise evolution of drug resistance via CNV and LOH. by Pétra Vande Zande (17628246)

Effects of SNPs on the Protein Stability, Increasing or Decreasing. by Mirza Jawad Ul Hasnain (8351388)

Fig 5 - by Sheona Isobel Shankland (19976311)

Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

“…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …”

EGCG treatment decreases TTR deposition and associated biomarkers in the gastrointestinal tract of old hTTR V30M mice. by Nelson Ferreira (188837)

Differential gene expression in WT and ESAM-KO pre CFU-E fraction after 5-FU treatment. by Takao Sudo (2625328)

“…(C) Venn diagram of the 65 genes that are shared between the genes that have more than a 2-fold increased or decreased expression in ESAM-KO pre CFU-E compared to WT pre CFU-E, and the “erythropoiesis”-related genes. …”

Variants enriched in an <i>Ae</i>. <i>aegypti</i> cell line <i>(</i>Aag2) have increased fitness in Aag2 cells but decreased fitness in a human cell line (MRC-5). by Chelsea Cereghino (15188341)

<i>IXR1</i> deletion restored the decreased expression of <i>CLB1</i> caused by <i>PUF5</i> deletion. by Megumi Sato (4116994)